Skip to main content
Top
Published in: Current Infectious Disease Reports 1/2015

01-01-2015 | Central Nervous System Infections (J Lyons, Section Editor)

Nervous System Lyme Disease

Author: John J. Halperin

Published in: Current Infectious Disease Reports | Issue 1/2015

Login to get access

Abstract

Lyme disease, a multisystem spirochetal infection, continues to be the subject of considerable debate, but not controversy. Recent years have seen improvements in diagnostic tools, better understanding of pathophysiology, and increasing evidence of efficacy of standard treatment regimens. Nervous system involvement is particularly confusing to patients and many physicians. A rational approach based on objective findings can clarify the cause and dictate the best treatment of patients’ difficulties. Diagnosis for all but the earliest cases rests on the combination of likely contact with infected Ixodes ticks and laboratory confirmation of exposure to the causative organism, Borrelia burgdorferi (two-tier serology, combining ELISA with a confirmatory Western blot). Treatment is generally with oral antimicrobials such as doxycycline. Parenteral regimens are usually necessary only for the most severe cases.
Literature
1.
go back to reference Fenney DP. Living with Lyme disease, searching for answers. The Des Moines Register 2014 July 27, 2014. Fenney DP. Living with Lyme disease, searching for answers. The Des Moines Register 2014 July 27, 2014.
2.
go back to reference Centers for Disease CP. Reported cases of Lyme disease—United States, 2012 [online]. Accessed July 30, 2014. Centers for Disease CP. Reported cases of Lyme disease—United States, 2012 [online]. Accessed July 30, 2014.
3.
go back to reference Hinckley AF, Connally NP, Meek JI, et al. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59(5):676–81. Hinckley AF, Connally NP, Meek JI, et al. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59(5):676–81.
4.
go back to reference Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685–98.CrossRefPubMed Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685–98.CrossRefPubMed
5.
go back to reference Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740–2.CrossRefPubMed Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740–2.CrossRefPubMed
6.
go back to reference Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733–40.CrossRefPubMed Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733–40.CrossRefPubMed
7.
go back to reference Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine. 1979;58:281–94.CrossRefPubMed Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine. 1979;58:281–94.CrossRefPubMed
8.
go back to reference Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch Dermatol Syphiligr. 1910;101:404. Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch Dermatol Syphiligr. 1910;101:404.
9.
go back to reference Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765–7. Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765–7.
10.
go back to reference Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22–6.CrossRefPubMed Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22–6.CrossRefPubMed
11.
go back to reference Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of erythema chronicum migrans Afzelius. Acta Derm Venereol. 1984;64:291–5.PubMed Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of erythema chronicum migrans Afzelius. Acta Derm Venereol. 1984;64:291–5.PubMed
12.
go back to reference Hollstrom E. Successful treatment of erythema migrans Afzelius. Acta Derm Venereol. 1951;31:235–43.PubMed Hollstrom E. Successful treatment of erythema migrans Afzelius. Acta Derm Venereol. 1951;31:235–43.PubMed
13.
go back to reference Ogrinc K, Lotric-Furlan S, Maraspin V, et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis. 2013;57:501–9.CrossRefPubMed Ogrinc K, Lotric-Furlan S, Maraspin V, et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis. 2013;57:501–9.CrossRefPubMed
14.
go back to reference Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279–90.CrossRefPubMed Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279–90.CrossRefPubMed
15.
go back to reference Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1–9.PubMedCentralPubMed Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1–9.PubMedCentralPubMed
16.
17.
go back to reference Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43:169–75.CrossRefPubMed Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43:169–75.CrossRefPubMed
18.
go back to reference Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis. 2013;57:333–40.CrossRefPubMed Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis. 2013;57:333–40.CrossRefPubMed
19.•
go back to reference Wormser GP, Schriefer M, Aguero-Rosenfeld ME, et al. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis. 2013;75:9–15. A good discussion of the issues regarding serologic testing and how to improve its sensitivity and specificity.CrossRefPubMedCentralPubMed Wormser GP, Schriefer M, Aguero-Rosenfeld ME, et al. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis. 2013;75:9–15. A good discussion of the issues regarding serologic testing and how to improve its sensitivity and specificity.CrossRefPubMedCentralPubMed
20.
go back to reference Schoen RT. Editorial commentary: better laboratory testing for Lyme disease: no more Western blot. Clin Infect Dis. 2013;57:341–3.CrossRefPubMed Schoen RT. Editorial commentary: better laboratory testing for Lyme disease: no more Western blot. Clin Infect Dis. 2013;57:341–3.CrossRefPubMed
21.
go back to reference Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol. 1985;21:819–25.PubMedCentralPubMed Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol. 1985;21:819–25.PubMedCentralPubMed
22.
go back to reference Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30:197–205.CrossRefPubMed Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30:197–205.CrossRefPubMed
23.
go back to reference Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 1989;39:753–9.CrossRefPubMed Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 1989;39:753–9.CrossRefPubMed
24.
go back to reference Henningsson AJ, Christiansson M, Tjernberg I, Lofgren S, Matussek A. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis. 2014;33:797–803.CrossRefPubMedCentralPubMed Henningsson AJ, Christiansson M, Tjernberg I, Lofgren S, Matussek A. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis. 2014;33:797–803.CrossRefPubMedCentralPubMed
25.
go back to reference Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.CrossRefPubMedCentralPubMed Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.CrossRefPubMedCentralPubMed
26.
go back to reference Sillanpaa H, Skogman BH, Sarvas H, Seppala IJ, Lahdenne P. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis. 2013;45:526–30.CrossRefPubMed Sillanpaa H, Skogman BH, Sarvas H, Seppala IJ, Lahdenne P. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis. 2013;45:526–30.CrossRefPubMed
27.
28.
go back to reference Pediatric Lyme Disease Study Group, Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. N Engl J Med. 1996;335:1270–4.CrossRef Pediatric Lyme Disease Study Group, Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. N Engl J Med. 1996;335:1270–4.CrossRef
29.
go back to reference Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987;107:725–31.CrossRefPubMed Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987;107:725–31.CrossRefPubMed
30.•
go back to reference Halperin JJ. Lyme disease—neurology, neurobiology and behavior. Clin Infect Dis. 2014;58:1267–72. A review of many of the neurobehavioral issues that have confounded our understanding of Lyme disease and its nervous system manifestations.CrossRefPubMed Halperin JJ. Lyme disease—neurology, neurobiology and behavior. Clin Infect Dis. 2014;58:1267–72. A review of many of the neurobehavioral issues that have confounded our understanding of Lyme disease and its nervous system manifestations.CrossRefPubMed
31.
go back to reference Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus". Arch Psychiatr Nervenkr. 1941;113:284–376.CrossRef Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus". Arch Psychiatr Nervenkr. 1941;113:284–376.CrossRef
32.
go back to reference Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med. 1983;99:767–72.CrossRefPubMed Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med. 1983;99:767–72.CrossRefPubMed
34.
go back to reference Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998;18:439–41.CrossRefPubMed Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998;18:439–41.CrossRefPubMed
35.
go back to reference Ackermann R, Rehse KB, Gollmer E, Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci. 1988;539:16–23.CrossRefPubMed Ackermann R, Rehse KB, Gollmer E, Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci. 1988;539:16–23.CrossRefPubMed
36.
go back to reference Kalina P, Decker A, Kornel E, Halperin JJ. Lyme disease of the brainstem. Neuroradiology. 2005;47:903–7.CrossRefPubMed Kalina P, Decker A, Kornel E, Halperin JJ. Lyme disease of the brainstem. Neuroradiology. 2005;47:903–7.CrossRefPubMed
37.••
go back to reference Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8–16. e11-14. An important overview of the diagnostic and therapeutic issues in European neuroborreliosis.CrossRefPubMed Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8–16. e11-14. An important overview of the diagnostic and therapeutic issues in European neuroborreliosis.CrossRefPubMed
38.
go back to reference Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis—peripheral nervous system manifestations. Brain. 1990;113:1207–21.CrossRefPubMed Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis—peripheral nervous system manifestations. Brain. 1990;113:1207–21.CrossRefPubMed
39.
go back to reference Sibony P, Halperin J, Coyle P, Patel K. Reactive Lyme serology in patients with optic neuritis and papilledema. J Neuro Ophthal. 2005;25:71–82.CrossRef Sibony P, Halperin J, Coyle P, Patel K. Reactive Lyme serology in patients with optic neuritis and papilledema. J Neuro Ophthal. 2005;25:71–82.CrossRef
40.
go back to reference Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol. 1991;48:1125–9.CrossRefPubMed Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol. 1991;48:1125–9.CrossRefPubMed
41.
go back to reference Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571–82.CrossRefPubMed Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571–82.CrossRefPubMed
42.
go back to reference Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340–3.CrossRefPubMed Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340–3.CrossRefPubMed
43.
go back to reference Luo N, Johnson J, Shaw J, Feeny D, Coons S. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078–86.CrossRefPubMed Luo N, Johnson J, Shaw J, Feeny D, Coons S. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078–86.CrossRefPubMed
44.•
go back to reference Klempner MS, Baker PJ, Shapiro ED, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126:665–9. A summary of treatment trials in post treatment Lyme disease.CrossRefPubMedCentralPubMed Klempner MS, Baker PJ, Shapiro ED, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126:665–9. A summary of treatment trials in post treatment Lyme disease.CrossRefPubMedCentralPubMed
45.
go back to reference Eikeland R, Mygland A, Herlofson K, Ljostad U. Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand. 2013;127:154–60.CrossRefPubMed Eikeland R, Mygland A, Herlofson K, Ljostad U. Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand. 2013;127:154–60.CrossRefPubMed
46.
go back to reference Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134.CrossRefPubMed Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134.CrossRefPubMed
47.
go back to reference Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69:91–102.CrossRefPubMed Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69:91–102.CrossRefPubMed
48.•
go back to reference Bremell D, Dotevall L. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension. Eur J Neurol. 2014;21:1162–7. Evidence that oral doxycycline may be effective in the most severe forms of nervous system Lyme disease.CrossRefPubMed Bremell D, Dotevall L. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension. Eur J Neurol. 2014;21:1162–7. Evidence that oral doxycycline may be effective in the most severe forms of nervous system Lyme disease.CrossRefPubMed
49.
go back to reference Halperin JJ. Oral treatment of parenchymal central nervous system neuroborreliosis—are we there yet? Eur J Neurol. 2014;21:1147–8.CrossRefPubMed Halperin JJ. Oral treatment of parenchymal central nervous system neuroborreliosis—are we there yet? Eur J Neurol. 2014;21:1147–8.CrossRefPubMed
Metadata
Title
Nervous System Lyme Disease
Author
John J. Halperin
Publication date
01-01-2015
Publisher
Springer US
Published in
Current Infectious Disease Reports / Issue 1/2015
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-014-0445-6

Other articles of this Issue 1/2015

Current Infectious Disease Reports 1/2015 Go to the issue

Skin, Soft Tissue, Bone and Joint Infectious Diseases (TS Dharmarajan, Section Editor)

Scabies in the Nursing Home

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Dengue: Update on Epidemiology

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Cholera in Travelers: Shifting Tides in Epidemiology, Management, and Prevention

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.